COMMUNIQUÉS West-GlobeNewswire

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter

22/10/2024 - 22:45

PROVIDENCE, Rhode Island, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. ( NASDAQ : OCEA), today announced that on October 16, 2024, it received a Staff Determination Letter from The Nasdaq Stock Market LLC (“ [...]

DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe

22/10/2024 - 22:45

Châtillon, France, October 22, 2024 DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe DBV to pursue an Accelerated Approval pathway for toddlers ages 1 – 3 years-old [...]

DBV annonce des avancées règlementaires positives pour le patch Viaskin® Peanut aux États-Unis et en Europe

22/10/2024 - 22:45

Châtillon, France, le 22 octobre (22 :15 CEST) 2024 DBV annonce des avancées règlementaires positives pour le patch Viaskin® Peanut aux États-Unis et en Europe Procédure d'approbation accélérée aux Etats-Unis pour les [...]

Sotera Health Announces Dates for Third-Quarter 2024 Earnings Release and November 2024 Investor Day

22/10/2024 - 22:30

CLEVELAND, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare [...]

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024

22/10/2024 - 22:30

Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 Mont-Saint-Guibert, Belgium – October 22, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company [...]

Nyxoah Publiera ses Résultats Financiers pour le Troisième Trimestre 2024 le 6 Novembre 2024

22/10/2024 - 22:30

Nyxoah Publiera ses Résultats Financiers pour le Troisième Trimestre 2024 le 6 Novembre 2024 Mont-Saint-Guibert, Belgium – 22 Octobre 2024, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » [...]

Treace to Report Third Quarter 2024 Financial Results on November 5, 2024

22/10/2024 - 22:30

PONTE VEDRA, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]

Arbor Biotechnologies to Highlight New Preclinical Data Supporting Advancement of Pipeline Programs and Knock-In Applicability of Type V Nucleases at Upcoming Medical and Scientific Meetings

22/10/2024 - 22:17

Oral presentation at ASN on lead program, ABO-101 for primary hyperoxaluria type 1 (PH1), supporting in vivo proof of pharmacology. On-track for year-end IND/CTA filing. Oral presentation at ALS One and a poster [...]

SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

22/10/2024 - 22:09

SANTA CLARA, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the third [...]

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

22/10/2024 - 22:05

MALVERN, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction, today announced that it has commenced an [...]

Arvinas Gives Back to Local Greater New Haven Community in Third Annual Impact Day

22/10/2024 - 22:05

NEW HAVEN, Conn., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that [...]

NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024

22/10/2024 - 22:05

MOUNTAIN VIEW, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report [...]

Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis

22/10/2024 - 22:05

SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a variety of [...]

OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th

22/10/2024 - 22:05

BETHLEHEM, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2024 financial results and certain business [...]

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

22/10/2024 - 22:05

SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients [...]

Ocuphire Pharma Announces Acquisition of Opus Genetics

22/10/2024 - 22:05

Acquisition creates a leading, clinical-stage company focused on the development of gene therapy treatments for rare inherited retinal degenerations New OPGx-LCA5 Phase 1/2 6-month data demonstrate safety and visual [...]

Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community

22/10/2024 - 22:05

WALTHAM, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]

Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer

22/10/2024 - 22:01

– VIRO-25 trial to assess efficacy & safety of olvimulogene nanivacirepvec (Olvi-Vec) & platinum-doublet + physician's choice of immune checkpoint inhibitor compared to docetaxel in recurrent non-small cell lung [...]

BioVie Inc. Announces Closing of Registered Direct Offering and Concurrent Private Placement

22/10/2024 - 22:01

CARSON CITY, Nev., Oct. 22, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions [...]